Cian Healthcare Ltd.
| BSE: 542678 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE05BN01019 |
| BSE 00:00 | 03 Dec | 17.20 |
-0.30 (-1.71%) |
OPEN
17.20 |
HIGH
17.20 |
LOW
17.20 |
| NSE 05:30 | 01 Jan | Cian Healthcare Ltd |
| OPEN | 17.20 |
| PREVIOUS CLOSE | 17.50 |
| VOLUME | 2000 |
| 52-Week high | 29.00 |
| 52-Week low | 10.40 |
| P/E | 101.18 |
| Mkt Cap.(Rs cr) | 40 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cian Healthcare Ltd. (CIANHEALTHCARE) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 674.35 | 1.00 | 0.15 | 3112.91 |
| Cipla | 911.85 | -9.60 | -1.04 | 2468.28 |
| Dr Reddy's Labs | 4598.00 | -64.45 | -1.38 | 2186.40 |
| Sun Pharma.Inds. | 751.80 | -14.35 | -1.87 | 2139.70 |
| Divi's Lab. | 4757.10 | -20.90 | -0.44 | 1954.72 |
| Alkem Lab | 3436.75 | -33.90 | -0.98 | 1685.08 |
| Glenmark Pharma. | 499.20 | -6.20 | -1.23 | 1649.45 |
| Cadila Health. | 459.85 | -0.55 | -0.12 | 1476.20 |
| Lupin | 873.10 | -2.60 | -0.30 | 1258.62 |
| Alembic Pharma | 808.35 | 5.00 | 0.62 | 1175.39 |
| Ipca Labs. | 2039.75 | -31.35 | -1.51 | 1140.77 |
| Torrent Pharma. | 2984.35 | 11.90 | 0.40 | 1137.85 |
| Gland Pharma | 3649.25 | 4.75 | 0.13 | 997.01 |
| Laurus Labs | 511.45 | -5.45 | -1.05 | 956.11 |
| Abbott India | 18890.90 | -141.00 | -0.74 | 690.69 |
| Ajanta Pharma | 2115.25 | -3.60 | -0.17 | 675.64 |
| Wockhardt | 441.10 | 10.00 | 2.32 | 593.29 |
| Granules India | 302.45 | 0.40 | 0.13 | 552.78 |
| Pfizer | 4914.70 | -18.85 | -0.38 | 497.61 |
| Sanofi India | 7878.65 | -15.30 | -0.19 | 477.60 |
Quick Links for Cian Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
